Conventional versus intensive T1DM tx not tied to menopause

January 9, 2014
Conventional versus intensive T1DM tx not tied to menopause

(HealthDay)—For women with type 1 diabetes, intensive versus conventional treatment is not associated with menopause risk, although greater insulin dose is associated with lower natural menopause risk, according to research published in Diabetes Care.

Catherine Kim, M.D., M.P.H., from the University of Michigan in Ann Arbor, and colleagues conducted a secondary analysis of 657 women with in the randomized Diabetes Control and Complications Trial (DCCT) and its observational follow-up, the Epidemiology of Diabetes Interventions and Complications (EDIC) study. The impact of intensive versus conventional treatment on was assessed.

After an average follow-up of 28 years, by EDIC year 18, the researchers found that 38 percent of women had experienced natural menopause and 18 percent had experienced surgical menopause. In intensive versus control groups, the ages at natural menopause (49.9 versus 49.0 years; P = 0.28) and surgical menopause (40.8 versus 42.0 years; P = 0.31) were similar. Treatment group, hemoglobin A1c (HbA1c), and microvascular complications were not linked to the risk of natural or surgical menopause in multivariate models. The risk of natural menopause was decreased with each 10 unit/day increase in insulin dosage (hazard ratio, 0.91), while each kg/m² increase in correlated with an elevated risk of surgical menopause (hazard ratio, 1.08).

"In the DCCT/EDIC, intensive versus conventional treatment group and HbA1c level were not associated with menopause risk," the authors write. "Greater insulin dose was associated with lower menopause risk."

Several pharmaceutical companies provided free or discounted supplies or equipment to support participants' adherence to the study.

Explore further: Cardiac function unaffected by prior intensive insulin therapy

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Cardiac function unaffected by prior intensive insulin therapy

April 12, 2013

(HealthDay)—There was no effect of intensive versus conventional insulin therapy during the Diabetes Control and Complications Trial (DCCT) on cardiac parameters as assessed by cardiac magnetic resonance (CMR) in the Epidemiology ...

Study ties early menopause to heart attack, stroke

September 28, 2012

Women who experience early menopause are more likely to have a heart attack or stroke than women whose menopause occurs at a later age, according to a new study by Melissa Wellons, M.D., assistant professor of Medicine in ...

Recommended for you

How does friendly fire happen in the pancreas?

October 21, 2016

In type 1 diabetes, the body attacks its own insulin-producing cells. Scientists at Helmholtz Zentrum München, partner in the German Center for Diabetes Research, and their colleagues at Technical University of Munich have ...

Diabetes opens floodgates to fructose

October 11, 2016

Fructose, once seen as diabetics' alternative to glucose, is fast-tracked to the liver in diabetic mice and contributes to metabolic diseases, according to new research from Harvard University.

Type 2 diabetes and obesity—what do we really know?

October 6, 2016

Social and economic factors have led to a dramatic rise in type 2 diabetes and obesity around the world. In a review in Science, Mark McCarthy, professor at the University of Oxford, UK, and Paul Franks, professor at Lund ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.